ARWR
ARWR
NASDAQ · Biotechnology

Arrowhead Pharmaceuticals In

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$72.69
-5.26 (-6.75%)
As of May 9, 9:34 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 15 79%
Hold 4 21%
Sell 0 0%
Price Target
Analyst Price Target -4.4% upside
Low Target $62.98
Average Target $69.50
High Target $88.85
Current Price $72.69
Current
$72.69
Target
$69.50
$62.98 $69.50 avg $88.85
Scenario Analysis
Bear Case
$62.98
-13.4%
Low target
Base Case
$69.50
-4.4%
Avg target
Bull Case
$88.85
+22.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$79.48
-8.5% from high
52-Week Low
$12.44
+484.3% from low
50-Day SMA
$66.84
+8.8% vs SMA
200-Day SMA
$36.65
+98.3% vs SMA
RSI (14)
36.5
Neutral
Target vs 52W High
$69.50
-12.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%